Restoring Hearing

Gene therapy that may reverse hearing loss

Innovators: Doug Brough and Lloyd Klickstein
Ages: Both 59 and 57
Titles: Chief scientific officer, GenVec; head of translational medicine, new indications discovery unit, Novartis Institutes for BioMedical Research.

Form and function: An experimental gene therapy may reverse hearing loss by stimulating the regrowth of microscopic sound-sensing hair cells in the inner ear destroyed by disease or prolonged exposure to loud noise.

ct_white_bar_1200
tech_innovation07_1200

 

Before it's here, it's on the Bloomberg Terminal.
LEARN MORE
Subscribe to Bloomberg Businessweek